GILEAD SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.84 USD | +0.21% |
|
+2.18% | -0.57% |
| 01-15 | Gilead Sciences, US government settle patent case over HIV prevention drugs | RE |
| 01-13 | Gilead to Seek M&A | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Other Pharmaceuticals | +0.21% | +2.18% | -0.57% | +6.30% | +45.82% | 114B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- GILD Stock
- Charts Gilead Sciences, Inc.
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition